Most of the new IPO's this year have been a lot of hype, with sky high expectations and not a lot to show for it. MDWD actually has a game changing burn treatment in trial (looks promising) -- with enormous demand for a new treatment other then surgery for serious burn patients. Due to the low volume of the IPO, it appears to be surprisingly, a bit under the radar, which is probably a good thing. Nice chance to load up on this one before the 20's.
Picked up some shares and am watching the trading. The institutional traders will move the stock as they add the stock to their portfolios and maybe FDA orphan drug status could happen for NexoBrid before Phase lll completion.
got in today in the 16s and very happy to do so, I work in the medical field and this is a nice one to be in. Didn't buy a ton just a few 100 shares but this stock can easily move with such a low float.